IRIS
PALOMBA, STEFANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.543
AS - Asia 618
EU - Europa 577
AF - Africa 26
Totale 2.764
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.519
CN - Cina 316
SG - Singapore 273
IT - Italia 165
NL - Olanda 101
DE - Germania 72
SE - Svezia 68
IE - Irlanda 60
FI - Finlandia 53
UA - Ucraina 26
CA - Canada 24
CI - Costa d'Avorio 24
GB - Regno Unito 18
IN - India 14
VN - Vietnam 8
BE - Belgio 3
FR - Francia 3
PH - Filippine 3
RU - Federazione Russa 3
HK - Hong Kong 2
NG - Nigeria 2
TR - Turchia 2
CZ - Repubblica Ceca 1
ES - Italia 1
GR - Grecia 1
PL - Polonia 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 2.764
Salva come PNG Salva come JPEG
Città #
Chandler 308
Singapore 218
Millbury 168
Princeton 114
Nanjing 105
Amsterdam 97
Naples 82
Jacksonville 68
Beijing 63
Wilmington 55
Santa Clara 54
Des Moines 45
Ashburn 42
Nanchang 30
Jiaxing 21
Shenyang 21
Boston 18
Hebei 18
Ottawa 16
Changsha 14
Dublin 14
Tianjin 13
Napoli 12
Seattle 12
Woodbridge 10
Dong Ket 8
Norwalk 8
Rome 7
Munich 6
Toronto 6
Washington 6
Boardman 5
Kronberg 5
Yellow Springs 5
Kunming 4
Lanzhou 4
Redwood City 4
Falls Church 3
Pune 3
Shanghai 3
Ahmedabad 2
Bagheria 2
Courcelles 2
Dallas 2
Enterprise 2
Helsinki 2
Hong Kong 2
Indiana 2
Los Angeles 2
New York 2
Redmond 2
Saint-Fons 2
Springfield 2
Tappahannock 2
Ann Arbor 1
Augusta 1
Bangalore 1
Bratislava 1
Brno 1
Brussels 1
Buffalo 1
Cambridge 1
Dearborn 1
Delhi 1
Duncan 1
Fort Worth 1
Frankfurt am Main 1
Fremont 1
Giugliano In Campania 1
Guangzhou 1
Handan 1
Jinan 1
Kolkata 1
Kumar 1
London 1
Long Beach 1
Madrid 1
Manduria 1
Markham 1
Milan 1
Newark 1
Ningbo 1
Port Harcourt 1
Quanzhou 1
Regensburg 1
Romano Di Lombardia 1
Rotterdam 1
Salerno 1
Samsun 1
San Diego 1
Sandston 1
Shijiazhuang 1
Simi Valley 1
Thessaloniki 1
Warsaw 1
Zhengzhou 1
Totale 1.765
Salva come PNG Salva come JPEG
Nome #
Lack of electrocardiographic changes in women with polycystic ovary syndrome. 67
Cardiopulmonary impairment in young women with polycystic ovary syndrome 56
Effects of neridronate treatment in elderly women with osteoporosis 52
Overexpression of the phosphoprotein enriched in diabetes gene product (Ped/pea-15) in women with polycystic ovary syndrome. 51
Effectiveness of alendronate treatment in postmenopausal women with osteoporosis: Relationship with Bsml vitamin D receptor genotypes 50
EFFECTS OF PHYSICAL EXERCISE ON THE FEMALE REPRODUCTIVE SYSTEM. 46
Obesity, type 2 diabetes mellitus and cardiovascular disease risk: an uptodate in the management of polycystic ovary syndrome 46
Improvement in endothelial structure and function after metformin treatment in young normal-weight women with polycystic ovary syndrome: results of a 6-month study 44
Leuprolide acetate treatment with and without coadministration of tibolone in premenopausal women with menstrual cycle-related irritable bowel syndrome. 43
Effects of metformin with or without supplementation with folate on homocysteine levels and vascular endothelium of women with polycystic ovary syndrome. 42
Oral contraceptives versus physical exercise on cardiovascular and metabolic risk factors in women with polycystic ovary syndrome: a randomized controlled trial 41
Lack of an association between peroxisome proliferator-activated receptor-gamma gene Pro12Ala polymorphism and adiponectin levels in the polycystic ovary syndrome 40
Is plasminogen activator inhibitor-1 a cardiovascular risk factor in young women with polycystic ovary syndrome? 38
Adrenal adenoma and normal androgen levels in a young woman with polycystic ovaries: a case of idiopathic hirsutism? 37
Dose reduction and discontinuation of alendronate in postmenopausal osteoporotic women who were receiving estrogen therapy 37
Cardiovascular complications of obesity in adolescents 37
Metabolic and cardiovascular consequences of polycystic ovary syndrome 37
Hypothalamic-pituitary-gonadal axis function after successful kidney transplantation in men and women 36
Lifestyle changes in the management of adulthood and childhood obesity. 36
Leuprolide acetate treatment with and without coadministration of tibolone in premenopausal women with menstrual cycle-related irritable bowel syndrome 36
Circulating ghrelin concentrations in the polycystic ovary syndrome 35
BsmI vitamin D receptor genotypes influence the efficacy of antiresorptive treatments in postmenopausal osteoporotic women. A 1-year multicenter, randomized and controlled trial 35
Homocysteine levels and C677T polymorphism of methylenetetrahydrofolate reductase in young women with polycystic ovary syndrome. 34
The increase of leukocytes as a new putative marker of low-grade chronic inflammation and early cardiovascular risk in polycystic ovary syndrome. 34
Evidence for altered adipocyte function in polycystic ovary syndrome 34
Cardiovascular risk in women with polycystic ovary sydrome 34
Beneficial treatment with risedronate in long-term survivors after allogeneic stem cell transplantation for hematological malignancies 34
The cardiovascular risk of young women with polycystic ovary syndrome: an observational, analytical, prospective case-control study 34
Adiponectin levels in women with polycystic ovary syndrome 33
Effectiveness of short-term administration of tibolone plus gonadotropin-releasing hormone analogue on the surgical outcome of laparoscopic myomectomy 33
Effectiveness of autocrosslinked hyaluronic acid gel after laparoscopic myomectomy in infertile patients: A prospective, randomized, controlled study 33
Endothelial dysfunction in PCOS: role of obesity and adipose hormones 32
Improvement in endothelial structure and function after metformin treatment in young normal-weight women with polycystic ovary syndrome: Results of a 6-month study 32
Genetic analysis of the follicle stimulating hormone receptor gene in women with polycystic ovary syndrome. 31
Inflammatory markers and visceral fat are inversely associated with maximal oxygen consumption in women with polycystic ovary syndrome 30
Serum aldosterone concentration and cardiovascular risk in women with polycystic ovarian syndrome 29
Efficacy of risedronate administration in osteoporotic postmenopausal women affected by inflammatory bowel disease 29
Effect of estrogen replacement plus low-dose alendronate treatment on bone density in surgically postmenopausal women with osteoporosis 29
Early impairment of endothelial structure and function in young normal-weight women with polycystic ovary syndrome 29
Early carotid atherosclerosis in normotensive severe obese premenopausal women with low DHEA(S). 29
Insulin sensitivity after metformin suspension in normal-weight women with polycystic ovary syndrome 29
Gonadal status in reproductive age women after haematopoietic stem cell transplantation for haematological malignancies 28
Metabolic and cardiopulmonary effects of detraining after a structured exercise training programme in young PCOS women 28
Visceral fat is associated with cardiovascular risk in women with polycystic ovary syndrome 28
Ovarian size and blood flow in women with polycystic ovary syndrome and their correlations with endocrine parameters 27
Bupivacaine plus epinephrine for laparoscopic myomectomy: A randomized placebo-controlled trial 27
Laparoscopic uterine nerve ablation versus vaginal uterosacral ligament resection in postmenopausal women with intractable midline chronic pelvic pain: A randomized study 26
A multicenter randomized, controlled study comparing laparoscopic versus minilaparotomic myomectomy: reproductive outcomes 26
Clomiphene citrate versus metformin as first-line approach for the treatment of anovulation in infertile patients with polycystic ovary syndrome 25
A prospective randomized comparison between laparoscopic and laparotomic approaches in women with early stage endometrial cancer: A focus on the quality of life 25
Effect of different doses of progestin on uterine leiomyomas in postmenopausal women 25
A randomized controlled trial comparing three single-incision minislings for stress urinary incontinence 24
Lack of an association between peroxisome proliferator-activated receptor-γ gene Pro12Ala polymorphism and adiponectin levels in the polycystic ovary syndrome 24
Is plasminogen activator inhibitor-1 a cardiovascular risk factor in young women with polycystic ovary syndrome? 24
Uterine effects of metformin administration in anovulatory women with polycystic ovary syndrome 24
Growth hormone secretion after baclofen administration in different phases of the menstrual cycle in healthy women 23
Polycystic ovary syndrome and obesity: non pharmacological approaches 23
Metformin administration and laparoscopic ovarian drilling improve ovarian response to clomiphene citrate (CC) in oligo-anovulatory CC-resistant women with polycystic ovary syndrome 23
Raloxifene administration in women treated with gonadotropin-releasing hormone agonist for uterine leiomyomas: effects on bone metabolism 23
Relationship between heart rate recovery and inflammatory markers in patients with polycystic ovary syndrome: a cross-sectional study 23
Does raloxifene inhibit the growth of uterine fibroids? [10] (multiple letters) 23
Bone metabolism in postmenopausal women who were treated with a gonadotropin-releasing hormone agonist and tibolone 23
Effects of raloxifene treatment on uterine leiomyomas in postmenopausal women 23
Prospective parallel randomized, double-blind, double-dummy controlled clinical trial comparing clomiphene citrate and metformin as the first-line treatment for ovulation induction in nonobese anovulatory women with polycystic ovary syndrome 22
Low 25 (OH) vitamin D levels are associated with autoimmune thyroid disease in polycystic ovary syndrome 22
Effect of tibolone on breast symptoms resulting from postmenopausal hormone replacement therapy 22
A multicenter randomized, controlled study comparing laparoscopic versus minilaparotomic myomectomy: short-term outcomes 22
Short-term administration of tibolone plus GnRH analog before laparoscopic myomectomy 22
Long-term effectiveness and safety of GnRH agonist plus raloxifene administration in women with uterine leiomyomas 20
Raloxifene administration in premenopausal women with uterine leiomyomas: a pilot study 20
Single-incision Mini-slings Versus Retropubic Tension-free Vaginal Tapes: A Multicenter Clinical Trial 20
Are laparoscopic ovarian diathermy and gonadotropin administration the only therapeutic second-steps in clomiphene-citrate resistant women with polycystic ovary syndrome? (multiple letters) [3] 20
Presurgical assessment of intraabdominal visceral fat in obese patients with early-stage endometrial cancer treated with laparoscopic approach: Relationships with early laparotomic conversions 20
Lipid, glucose and homocysteine metabolism in women treated with a GnRH agonist with or without raloxifene 19
Effect of preconceptional metformin on abortion risk in polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials 19
Effects of metformin with or without supplementation with folate on homocysteine levels and vascular endothelium of women with polycystic ovary syndrome 19
Laparoscopic ovarian diathermy vs clomiphene citrate plus metformin as second-line strategy for infertile anovulatory patients with polycystic ovary syndrome: a randomized controlled trial 19
Metformin administration versus laparoscopic ovarian diathermy in clomiphene citrate-resistant women with polycystic ovary syndrome: a prospective parallel randomized double-blind placebo-controlled trial 19
Laparoscopic burch colposuspension: A randomized controlled trial comparing two transperitoneal surgical techniques 19
Management strategies for ovulation induction in women with polycystic ovary syndrome and known clomifene citrate resistance 18
Updating of a recent meta-analysis of randomized controlled trials to assess the safety and the efficacy of the laparoscopic surgery for treating early stage endometrial cancer 18
Two techniques of laparoscopic retropubic urethropexy 18
Effectiveness of presacral neurectomy in women with severe dysmenorrhea caused by endometriosis who were treated with laparoscopic conservative surgery: A 1-year prospective randomized double-blind controlled trial 18
GH release after GHRH plus arginine administration in obese and overweight women with polycystic ovary syndrome 17
Laparoscopic colposuspension using sutures or prolene meshes: A 3-year follow-up 17
Visceral fat amount as predictive factor for early laparotomic conversion in obese patients with endometrial cancer 17
Randomized Controlled Study Comparing the Gynecare Morcellex and Rotocut G1 Tissue Morcellators 17
Exon 6 and 2 Peroxisome Proliferator-Activated Receptor-γ Polymorphisms in Polycystic Ovary Syndrome 17
Uterine effects of clomiphene citrate in women with polycystic ovary syndrome: a prospective controlled study 16
Lipid profile in nonobese pregnant women with polycystic ovary syndrome: A prospective controlled clinical study 16
Laparoscopic surgery vs laparotomy for early stage endometrial cancer: long-term data of a randomized controlled trial 16
A randomized controlled trial evaluating metformin pre-treatment and co-administration in non-obese insulin-resistant women with polycystic ovary syndrome treated with controlled ovarian stimulation plus timed intercourse or intrauterine insemination 16
Evidence-based and potential benefits of metformin in the polycystic ovary syndrome: A comprehensive review 16
Structured exercise training programme versus hypocaloric hyperproteic diet in obese polycystic ovary syndrome patients with anovulatory infertility: a 24-week pilot study 15
Efficacy predictors for metformin and clomiphene citrate treatment in anovulatory infertile patients with polycystic ovary syndrome 15
Raloxifene administration in premenopausal women with uterine leiomyomas: A pilot study 15
Long-term Effectiveness of Presacral Neurectomy for the Treatment of Severe Dysmenorrhea Due to Endometriosis 15
Transdermal hormone replacement therapy in postmenopausal women with uterine leiomyomas 15
Laparoscopic treatment for endometrial cancer: A meta-analysis of randomized controlled trials (RCTs) 14
What is the best first-step therapeutic approach in treating anovulatory infertility in patients with polycystic ovary syndrome? Questions that are still unanswered 14
Totale 2.753
Salva come PNG Salva come JPEG
Categoria #
all - tutte 16.063
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.063
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020133 0 0 0 0 0 2 2 0 1 39 41 48
2020/2021112 2 6 14 11 6 34 10 1 9 2 8 9
2021/2022600 5 0 0 4 9 54 2 25 53 57 109 282
2022/2023753 123 57 22 64 88 72 11 57 110 91 48 10
2023/2024449 21 84 110 26 18 26 0 42 4 2 67 49
2024/2025352 132 114 21 23 43 19 0 0 0 0 0 0
Totale 2.905